Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral fluid-percussion injury in the rat

Journal of Neurosurgery

Volumn 102, Issue 6, 2005, Pages 1115-1121

  Kleindienst, Andrea ^a   Tolias, Christos M ^b   Corwin, Frank D ^b   Müller, Christian ^b   Marmarou, Anthony ^b   Fatouros, Panos ^b   Bullock, M Ross ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Prognosis; Proton magnetic resonance spectroscopy; Rat; S100B protein; Traumatic brain injury

Indexed keywords

PROTEIN S100B; BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100; PROTON; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; HEMISPHERE; IN VITRO STUDY; MALE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TRAUMATIC BRAIN INJURY; ANIMAL; BLOOD; BRAIN INJURY; FEASIBILITY STUDY; HOSPITALIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; FEASIBILITY STUDIES; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE GROWTH FACTORS; PROGNOSIS; PROTONS; RATS; RATS, SPRAGUE-DAWLEY; S100 PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 23144447444     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.102.6.1115     Document Type: Article

References (44)

1. Agelink MW, Andrich J, Postert T, Würzinger U, Zeit T, Klotz P, et al: Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 71:394-396, 2001
2. Barger SW, Van Eldik LJ, Mattson MP: S100β protects hippocampal neurons from damage induced by glucose deprivation. Brain Res 677:167-170, 1995
3. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, et al: Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31, 2002
4. 1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes. Glia 27: 275-281, 1999
5. de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A: S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with healthy controls. Acta Neurol Scand 103:175-179, 2001
6. Dixon CE, Lyeth BG, Povlishock JT, Findling RL, Hamm RJ, Marmarou A, et al: A fluid percussion model of experimental brain injury in the rat. J Neurosurg 67:110-119, 1987
7. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637-668, 2001
8. Donato R: S-100 proteins. Cell Calcium 7:123-145, 1986
9. Green AJE, Keir G, Thompson EJ: A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J Immunol Methods 205:35-41, 1997
10. Heizmann CW, Fritz G, Schäfer BW: S100 proteins: structure, functions and pathology. Front Biosci 7:d1356-d1368, 2002
11. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, et al: Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 70:95-100, 2001
12. Herrmann M, Jost S, Kutz S, Ebert AD, Kratz T, Wunderlich MT, et al: Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 17:113-122, 2000
13. Hilton G: Behavioral and cognitive sequelae of head trauma. Orthop Nurs 13:25-32, 1994
14. Hu J, Ferreira A, Van Eldik LJ: S100β induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 69: 2294-2301, 1997
15. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H: Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105, 2000
16. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, et al: The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 14:1047-1055, 2000
17. Jackson RG, Samra GS, Radcliffe J, Clark GH, Price CP: The early fall in levels of S-100 beta in traumatic brain injury. Clin Chem Lab Med 38:1165-1167, 2000
18. Kleindienst A, Harvey HB, Rice AC, Müller C, Hamm RJ, Gaab MR, et al: Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat. J Neurotrauma 21:541-547, 2004
19. Kligman D, Marshak DR: Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 82:7136-7139, 1985
20. Kragh J, Bolwig TG, Woldbye DP, Jorgensen OS: Electroconvulsive shock and lidocaine-induced seizures in the rat activate astrocytes as measured by glial fibrillary acidic protein. Biol Psychiatry 33:794-800, 1993
21. Kraus JF, McArthur DL: Epidemiologic aspects of brain injury. Neurol Clin 14:435-450, 1996
22. Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, et al: S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 71: 1421-1428, 1998
23. Matsutani T, Nagayoshi M, Tamaru M, Hirata Y, Kato K: Changes in the levels of neural cell specific proteins in the developing rat brain. Neurochem Res 10:1155-1172, 1985
24. Mello e Souza T, Rohden A, Meinhardt M, Goncalves CA, Quillfeldt JA: S100B infusion into the rat hippocampus facilitates memory for the inhibitory avoidance task but not for the openfield habituation. Physiol Behav 71:29-33, 2000
25. O'Dowd BS, Zhao WQ, Ng KT, Robinson SR: Chicks injected with antisera to either S-100α or S-100β protein develop amnesia for a passive avoidance task. Neurobiol Learn Mem 67: 197-206, 1997
26. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. Orlando: Academic Press, 1986
27. Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ: Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int 39:409-413, 2001
28. Petrova TV, Hu J, Van Eldik LJ: Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res 853:74-80, 2000
29. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T: S-100β reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 18:491-498, 2001
30. Raabe A, Seifert V: Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg Rev 23:136-138, 2000
31. Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA: Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res 326:47-63, 1985
32. Rickmann M, Wolff JR, Meyer DL: Expression of S100 protein in the vestibular nuclei during compensation of unilateral labyrinthectomy symptoms. Brain Res 688:8-14, 1995
33. Rothermundt M, Peters M, Prehn JH, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech 60:614-632, 2003
34. Rothoerl RD, Brawanski A, Woertgen C: S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir 142:199-203, 2000
35. 2+-dependent interaction of S100Bββ with a peptide derived from p53. Biochemistry 37:1951-1960, 1998
36. Shashoua VE, Hesse GW, Moore BW: Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J Neurochem 42:1536-1541, 1984
37. Slemmer JE, Matser EJ, De Zeeuw CI, Weber JT: Repeated mild injury causes cumulative damage to hippocampal cells. Brain 125:2699-2709, 2002
38. Van Eldik LJ, Wainwright MS: The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21:97-108, 2003
39. Van Eldik LJ, Zimmer DB: Secretion of S-100 from rat C6 glioma cells. Brain Res 436:367-370, 1987
40. Whitaker-Azmitia PM, Murphy R, Azmitia EC: Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 528: 155-158, 1990
41. 2+-dependent manner. Protein Sci 7: 794-798, 1998
42. Winningham-Major F, Staecker JL, Barger SW, Coats S, Van Eldik LJ: Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J Cell Biol 109:3063-3071, 1989
43. Woertgen C, Rothoerl RD, Brawanski A: Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J Neurotrauma 18:569-573, 2001
44. Zimmer DB, Van Eldik LJ: Identification of a molecular target for the calcium-modulated protein S100. Fructose-1,6-bisphosphate aldolase. J Biol Chem 261:11424-11428, 1986